GenScript, the foremost supplier of life-science research instruments and services, has enlarged its main facility for the synthesis of oligonucleotides and peptides in Zhenjiang, Jiangsu, China. The expansion builds on GenScript's history of providing top-notch oligo and peptides to scientists all across the world for 20 years.

To enable a wide range of applications, including molecular diagnostics, RNAi, and genome editing, the extended oligonucleotide synthesis capabilities provide qPCR oligos, NGS oligos, RNA oligos, DNA oligos, and more.

GenScript offers up to 200nt DNA and 180nt RNA oligonucleotides from ug to kilogram level with up to 95% purity to meet a variety of application needs. GenScript is equipped with high-throughput, large-scale synthesisers, HPLC+, and PAGE+ purification processes for stringent cross-contamination control.

Similarly, GenScript has been accelerating research efforts by providing high-quality bespoke peptides and peptide libraries with 100% assured quantity at industry-leading speed—as short as 5 days—using its patented, microwave-assisted PepPowerTM peptide synthesis platform.

With this addition, four new dynamic axial compression columns for large-scale peptide production have been installed, resulting in an average monthly production capacity of more than 5kg, as well as 32 square feet of freeze dryers to assist the mass freeze-drying procedure. GenScript is now able to deliver up to 30,000 peptides each month and provide kilogram-level batch production thanks to newly enlarged production lines.

Dr. Ray Chen, president of the Life Science Group at GenScript said "GenScript's new site in Zhenjiang is poised to offer unparalleled support and address the increasing demand for oligonucleotide and peptide synthesis — serving the areas such as molecular diagnostics, RNA, and peptide drug development, vaccine development, gene editing by providing faster, more reliable, and more cost-effective solutions via our cutting-edge platforms at different scales."

GenScript is committed to helping peptide researchers in fields including functional screening and neoantigen discovery, as well as peptide medication and vaccine development.